The Role of Real-World Evidence (RWE) in Thoracic Malignancies
A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Thoracic Oncology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 550
Special Issue Editors
2. Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada
Interests: thoracic malignancies; carcinoma unknown primary; real world evidence; medical education; advocacy
Special Issues, Collections and Topics in MDPI journals
Interests: clinical care; thoracic oncology; head and neck oncology; clinical Trials; evaluating factors that could impact survivorship in the treatment of thoracic and head/neck cancers; medical education; real world evidence generation
Special Issue Information
Dear Colleagues,
Real-world data (RWD) and real-world evidence (RWE) are increasingly important components of a broad research portfolio. RWE has the ability to see clinical care as it really is, complicated and messy, full of idiosyncrasies and oddities that are excluded from the purified world of prospective clinical trials. RWE is now accepted by regulatory bodies such as the FDA, NICE, EMA, and Health Canada, sometimes in a supportive role and sometimes as primary data. In lung cancer, the explosion of rare subtypes is a fertile opportunity for RWE research, but also, with lung cancer being so common, it is possible to generate RWE for large numbers of patients to answer different questions.
In this Special Issue of Current Oncology, we invite submissions of RWE projects with clinical data or papers on the methodology and challenges of RWE. We are interested in the future of RWE, which might involve AI, the increasing capacity of EMRs, or the novel field of synthetic data. By fostering a dialogue around RWE, we aspire to advance the field of thoracic oncology and improve patient care, ultimately leading to better outcomes for those affected by this disease.
We look forward to your submissions.
Dr. Paul Wheatley-Price
Dr. Sara Kuruvilla
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- real-world evidence (RWE)
- real word data (RWD)
- lung cancer
- thoracic cancers (malignancies)
- observational studies
- health economic outcomes research (HEOR)
- registry(ies)
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
